ECM
ELV icon

ExodusPoint Capital Management’s Elevance Health ELV Stock Holding History

ExodusPoint Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6M Buy
+37,855
New +$14M 0.09% 198
2026
Q1 		– Sell
-18,807
Closed -$6.59M – 1689
2025
Q4 		$6.59M Buy
+18,807
New +$6.36M 0.05% 380
2025
Q3 		– Sell
-22,440
Closed -$8.73M – 1666
2025
Q2 		$8.73M Buy
+22,440
New +$9.03M 0.08% 267
2025
Q1 		– Sell
-13,587
Closed -$5.01M – 1603
2024
Q4 		$5.01M Sell
13,587
-73,591
-84% -$30.8M 0.03% 442
2024
Q3 		$45.3M Buy
87,178
+47,912
+122% +$25.6M 0.28% 50
2024
Q2 		$21.3M Buy
39,266
+16,057
+69% +$8.49M 0.15% 121
2024
Q1 		$12M Buy
23,209
+13,578
+141% +$6.75M 0.09% 182
2023
Q4 		$4.54M Sell
9,631
-9,221
-49% -$4.26M 0.03% 365
2023
Q3 		$8.21M Sell
18,852
-11,411
-38% -$5.18M 0.08% 262
2023
Q2 		$13.4M Buy
30,263
+12,829
+74% +$5.92M 0.11% 189
2023
Q1 		$8.02M Buy
17,434
+15,150
+663% +$7.21M 0.07% 356
2022
Q4 		$1.17M Sell
2,284
-6,708
-75% -$3.41M 0.02% 879
2022
Q3 		$4.08M Buy
8,992
+1,759
+24% +$842K 0.05% 478
2022
Q2 		$3.49M Buy
+7,233
New +$3.58M 0.04% 543
2022
Q1 		– Sell
-20,775
Closed -$9.63M – 2309
2021
Q4 		$9.63M Buy
+20,775
New +$8.74M 0.1% 231
2021
Q3 		– Sell
-8,408
Closed -$3.21M – 2245
2021
Q2 		$3.21M Sell
8,408
-8,769
-51% -$3.35M 0.04% 493
2021
Q1 		$6.17M Sell
17,177
-2,280
-12% -$733K 0.09% 216
2020
Q4 		$6.25M Sell
19,457
-5,120
-21% -$1.57M 0.06% 203
2020
Q3 		$6.6M Buy
24,577
+11,912
+94% +$3.21M 0.13% 140
2020
Q2 		$3.33M Buy
12,665
+9,375
+285% +$2.5M 0.09% 260
2020
Q1 		$747K Buy
+3,290
New +$897K 0.04% 365
2019
Q4 		– Sell
-7,235
Closed -$1.74M – 1622
2019
Q3 		$1.74M Buy
7,235
+6,353
+720% +$1.74M 0.06% 268
2019
Q2 		$249K Sell
882
-7,192
-89% -$1.96M 0.01% 794
2019
Q1 		$2.32M Buy
8,074
+6,957
+623% +$2.01M 0.17% 93
2018
Q4 		$293K Buy
+1,117
New +$307K 0.02% 201

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ExodusPoint Capital Management's ELV Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Elevance Health (ELV) in Q2 2026: 37,855 shares worth $14.6M. The stake represents 0.09% of the portfolio and ranks #198 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in ELV as recently as Q4 2025.

ExodusPoint Capital Management first reported a position in ELV in Q4 2018 and has held it in 25 quarters since. The position peaked at $45.3M in Q3 2024. 1,611 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ExodusPoint Capital Management held 37,855 shares of Elevance Health worth $14.6M as of Q2 2026.
  • Elevance Health was a new ExodusPoint Capital Management position in Q2 2026.
  • Elevance Health made up 0.09% of ExodusPoint Capital Management's portfolio in Q2 2026, its #198 holding.
  • ExodusPoint Capital Management first reported a position in Elevance Health in Q4 2018 and has held it in 25 quarters since.
  • ExodusPoint Capital Management's Elevance Health position peaked at $45.3M in Q3 2024.
  • 1,611 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.